Clinical trial
Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic…
NCT00361543 · The Alfred, Other · Completed
Key facts
| NCT number | NCT00361543 |
|---|---|
| Title | Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia |
| Official title | Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia? |
| Acronym | SERM |
| Lead sponsor | The Alfred, Other |
| Collaborators | Stanley Medical Research Institute National Health and Medical Research Council, Australia |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder |
| Intervention type | Drug, Other |
| Interventions | Raloxifene hydrochloride, Lactose Capsules |
| Enrollment | 54 |
| Start date | Aug 1, 2006 |
| Primary completion | Dec 1, 2014 |
| Completion | Dec 1, 2014 |
| First posted | Aug 8, 2006 |
| Last update posted | Jan 30, 2015 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: